RANDOMIZED PHASE II CLINICAL TRIAL OF TAILORED IRINOTECAN (CPT-11) PLUS S-1 VERSUS S-1 IN PATIENTS WITH ADVANCED OR RECURRENT GASTRIC CARCINOMA AS THE FIRST-LINE CHEMOTHERAPY (THE JAPANESE FOUNDATION FOR MULTIDISCIPLINARY TREATMENT OF CANCER, JFMC31-0301)

被引：0
|
作者：
Takahashi, Y. [1 ]
Komatsu, Y. [2 ]
Kitajima, M. [3 ]
Kubota, T. [4 ]
Saji, S. [5 ]
Nishiyama, M. [6 ]
Kimura, Y. [7 ]
Oda, H. [8 ]
Tajima, Y. [9 ]
Miki, H. [10 ]
机构：
[1] Chiba Univ, Chiba, Japan
[2] Hokkaido Univ Hosp, Ctr Canc, Sapporo, Hokkaido 060, Japan
[3] Int Univ Hlth & WelfareS, Tokyo, Japan
[4] Keio Univ, Ctr Comprehens & Adv Med, Tokyo, Japan
[5] Japanese Fdn Multidisciplinary Treatment Canc, Tokyo, Japan
[6] Saitma Med Univ, Int Med Ctr, Translat Tesearch Ctr, Hidaka, Saitama, Japan
[7] NTT W Osaka Hosp, Osaka, Japan
[8] Kushiro Rosai Hosp, Kushiro, Hokkaido, Japan
[9] Showa Univ, Sch Med, Tokyo 142, Japan
[10] Kansai Rosai Hosp, Amagasaki, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：172 / 172
页数：1
相关论文
共 50 条
  • [1] Randomized phase II trial of first-line treatment with tailored irinotecan and S-1 therapy versus S-1 monotherapy for advanced or recurrent gastric carcinoma (JFMC31-0301)
    Komatsu, Yoshito
    Takahashi, Yutaka
    Kimura, Yutaka
    Oda, Hisashi
    Tajima, Yusuke
    Tamura, Shigeyuki
    Sakurai, Jo
    Wakasugi, Takehiro
    Tatebe, Shigeru
    Takahashi, Masahiro
    Sakata, Yuh
    Kitajima, Masaki
    Sakamoto, Junichi
    Saji, Shigetoyo
    ANTI-CANCER DRUGS, 2011, 22 (06) : 576 - 583
  • [2] A randomized phase II clinical trial of tailored CPT-11+S-1 vs S-1 in patients with advanced or recurrent gastric carcinoma as the first line chemotherapy
    Takahashi, Y
    Sakamoto, J
    Takeuchi, T
    Mai, M
    Kubota, T
    Kitajima, M
    Tanigawara, Y
    Komatsu, Y
    Toge, T
    Saji, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (06) : 342 - 345
  • [3] Randomized Phase II Trial of S-1 plus Irinotecan Versus S-1 plus Paclitaxel as First-line Treatment for Advanced Gastric Cancer (OGSG0402)
    Sugimoto, Naotoshi
    Fujitani, Kazumasa
    Imamura, Hiroshi
    Uedo, Noriya
    Iijima, Shohei
    Imano, Motohiro
    Shimokawa, Toshio
    Kurokawa, Yukinori
    Furukawa, Hiroshi
    Goto, Masahiro
    ANTICANCER RESEARCH, 2014, 34 (02) : 851 - 857
  • [4] RANDOMIZED PHASE II TRIAL OF S-1 PLUS IRINOTECAN VERSUS S-1 PLUS PACLITAXEL AS FIRST-LINE TREATMENT FOR ADVANCED GASTRIC CANCER (OGSG0402)
    Fujitani, K.
    Takiuchi, H.
    Sugimoto, N.
    Imamura, H.
    Iijima, S.
    Imano, M.
    Kimura, Y.
    Kurokawa, Y.
    Tsujinaka, T.
    Furukawa, H.
    ANNALS OF ONCOLOGY, 2010, 21 : 256 - 256
  • [5] Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 in patients with advanced gastric cancer refractory to S-1 or S-1 plus CDDP.
    Kawase, Tomono
    Imamura, Hiroshi
    Gotoh, Masahiro
    Kimura, Yutaka
    Ueda, Shugo
    Matsuyama, Jin
    Nishikawa, Kazuhiro
    Sugimoto, Naotoshi
    Fujita, Junya
    Tamura, Takao
    Fukushima, Norimasa
    Kawabata, Ryohei
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Sakai, Daisuke
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Phase I/II study of irinotecan (CPT-11) and S-1 in the treatment of advanced gastric cancer
    Katsube, Takao
    Ogawa, Kenji
    Ichikawa, Wataru
    Fujii, Masashi
    Tokunaga, Akira
    Takagi, Yuh
    Kochi, Misugu
    Hayashi, Kazuhiko
    Kubota, Tetsuro
    Aiba, Keisuke
    Arai, Kuniyoshi
    Terashima, Masanori
    Kitajima, Masaki
    ANTI-CANCER DRUGS, 2007, 18 (05) : 605 - 610
  • [7] Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer (OGSG0402): Final report
    Kishimoto, T.
    Imamura, H.
    Uedou, F.
    Fujitani, K.
    Iijima, S.
    Takiuchi, H.
    Imano, M.
    Shimokawa, T.
    Kurokawa, Y.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Combination therapy with S-1 and irinotecan (CPT-11) for advanced or recurrent gastric cancer
    Takiuchi, Hiroya
    GASTRIC CANCER, 2009, 12 : 55 - 59
  • [9] Combination therapy with S-1 and irinotecan (CPT-11) for advanced or recurrent gastric cancer
    Hiroya Takiuchi
    Gastric Cancer, 2009, 12 : 55 - 59
  • [10] A randomized phase III trial of second-line chemotherapy comparing CPT-11 alone versus S-1 plus CPT-11 combination therapy in advanced gastric cancer refractory to first-line therapy with S-1 (JACCRO GC-05)
    Nishikawa, Kazuhiro
    Tanabe, Kazuaki
    Fujii, Masashi
    Kunisaki, Chikara
    Tsuji, Akihito
    Matsuhashi, Nobuhisa
    Takagane, Akinori
    Ohno, Tetsuro
    Kawase, Tomono
    Kochi, Mitsugu
    Yoshida, Kazuhiro
    Kakeji, Yoshihiro
    Ichikawa, Wataru
    Chin, Keisho
    Terashima, Masanori
    Takeuchi, Masahiro
    Nakajima, Toshifusa
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345